(SJM) The J. M. Smucker - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8326964058
Stock: Coffee, Peanut Butter, Pet Food, Frozen Snacks
Total Rating 30
Risk 64
Buy Signal 0.00
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.01% |
| Yield on Cost 5y | 5.60% |
| Yield CAGR 5y | 3.63% |
| Payout Consistency | 96.0% |
| Payout Ratio | 49.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 24.6% |
| Relative Tail Risk | -5.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.35 |
| Alpha | 3.10 |
| Character TTM | |
|---|---|
| Beta | 0.205 |
| Beta Downside | 0.204 |
| Drawdowns 3y | |
|---|---|
| Max DD | 35.75% |
| CAGR/Max DD | -0.19 |
Description: SJM The J. M. Smucker January 03, 2026
The J.M. Smucker Company (NYSE:SJM) is a diversified branded food and beverage maker that sells coffee, spreads, pet foods, and sweet baked snacks through four U.S. retail-focused segments. Its portfolio includes household names such as Folgers, Café Bustelo, Jif, Smucker’s, Meow Mix, Milk-Bone, Hostess, and Five Roses, and it reaches consumers via supermarkets, club stores, discount outlets, online channels, pet-specialty retailers, and food-service distributors.
Key recent metrics: FY 2023 net sales were about $8.2 billion, with the pet-food segment posting a 6% year-over-year revenue increase driven by premium-price growth and expanding e-commerce penetration. The U.S. retail coffee business saw margin compression as coffee bean prices rose 12% YoY, while the sweet baked snacks line benefited from a 4% uplift in promotional lift after the Hostess acquisition. Macro drivers include persistent inflation pressure on commodity costs, a gradual shift toward private-label competition, and steady consumer demand for convenient, on-the-go snack solutions.
For a deeper quantitative view, see the SJM analysis on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -1.19b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.96 > 1.0 |
| NWC/Revenue: -3.43% < 20% (prev -17.07%; Δ 13.64% < -1%) |
| CFO/TA 0.05 > 3% & CFO 969.2m > Net Income -1.19b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.89 > 1.5 & < 3 |
| Outstanding Shares: last quarter (106.9m) vs 12m ago 0.19% < -2% |
| Gross Margin: 33.72% > 18% (prev 0.39%; Δ 3333 % > 0.5%) |
| Asset Turnover: 46.61% > 50% (prev 44.11%; Δ 2.49% > 0%) |
| Interest Coverage Ratio: -1.86 > 6 (EBITDA TTM -188.5m / Interest Expense TTM 382.4m) |
Altman Z'' -0.25
| A: -0.02 (Total Current Assets 2.33b - Total Current Liabilities 2.63b) / Total Assets 17.63b |
| B: 0.03 (Retained Earnings 468.2m / Total Assets 17.63b) |
| C: -0.04 (EBIT TTM -712.5m / Avg Total Assets 18.82b) |
| D: 0.03 (Book Value of Equity 312.2m / Total Liabilities 11.57b) |
| Altman-Z'' Score: -0.25 = B |
Beneish M -3.18
| DSRI: 0.84 (Receivables 675.2m/804.6m, Revenue 8.77b/8.83b) |
| GMI: 1.15 (GM 33.72% / 38.72%) |
| AQI: 0.95 (AQ_t 0.70 / AQ_t-1 0.74) |
| SGI: 0.99 (Revenue 8.77b / 8.83b) |
| TATA: -0.12 (NI -1.19b - CFO 969.2m) / TA 17.63b) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of SJM shares?
As of February 07, 2026, the stock is trading at USD 109.51 with a total of 1,272,171 shares traded.
Over the past week, the price has changed by +4.43%, over one month by +14.18%, over three months by +5.43% and over the past year by +10.43%.
Over the past week, the price has changed by +4.43%, over one month by +14.18%, over three months by +5.43% and over the past year by +10.43%.
Is SJM a buy, sell or hold?
The J. M. Smucker has received a consensus analysts rating of 3.55.
Therefor, it is recommend to hold SJM.
- StrongBuy: 5
- Buy: 2
- Hold: 12
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the SJM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 114.9 | 4.9% |
| Analysts Target Price | 114.9 | 4.9% |
| ValueRay Target Price | 112 | 2.2% |
SJM Fundamental Data Overview February 04, 2026
P/E Forward = 10.9051
P/S = 1.2744
P/B = 1.8461
P/EG = 1.6776
Revenue TTM = 8.77b USD
EBIT TTM = -712.5m USD
EBITDA TTM = -188.5m USD
Long Term Debt = 7.04b USD (from longTermDebt, last quarter)
Short Term Debt = 748.2m USD (from shortTermDebt, last quarter)
Debt = 7.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.85b USD (from netDebt column, last quarter)
Enterprise Value = 19.03b USD (11.18b + Debt 7.91b - CCE 62.8m)
Interest Coverage Ratio = -1.86 (Ebit TTM -712.5m / Interest Expense TTM 382.4m)
EV/FCF = 29.95x (Enterprise Value 19.03b / FCF TTM 635.5m)
FCF Yield = 3.34% (FCF TTM 635.5m / Enterprise Value 19.03b)
FCF Margin = 7.24% (FCF TTM 635.5m / Revenue TTM 8.77b)
Net Margin = -13.61% (Net Income TTM -1.19b / Revenue TTM 8.77b)
Gross Margin = 33.72% ((Revenue TTM 8.77b - Cost of Revenue TTM 5.82b) / Revenue TTM)
Gross Margin QoQ = 33.56% (prev 22.46%)
Tobins Q-Ratio = 1.08 (Enterprise Value 19.03b / Total Assets 17.63b)
Interest Expense / Debt = 1.25% (Interest Expense 98.6m / Debt 7.91b)
Taxrate = 24.21% (77.1m / 318.4m)
NOPAT = -540.0m (EBIT -712.5m * (1 - 24.21%)) [loss with tax shield]
Current Ratio = 0.89 (Total Current Assets 2.33b / Total Current Liabilities 2.63b)
Debt / Equity = 1.31 (Debt 7.91b / totalStockholderEquity, last quarter 6.06b)
Debt / EBITDA = -41.65 (negative EBITDA) (Net Debt 7.85b / EBITDA -188.5m)
Debt / FCF = 12.35 (Net Debt 7.85b / FCF TTM 635.5m)
Total Stockholder Equity = 6.24b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.34% (Net Income -1.19b / Total Assets 17.63b)
RoE = -19.12% (Net Income TTM -1.19b / Total Stockholder Equity 6.24b)
RoCE = -5.36% (EBIT -712.5m / Capital Employed (Equity 6.24b + L.T.Debt 7.04b))
RoIC = -3.84% (negative operating profit) (NOPAT -540.0m / Invested Capital 14.07b)
WACC = 4.30% (E(11.18b)/V(19.09b) * Re(6.67%) + D(7.91b)/V(19.09b) * Rd(1.25%) * (1-Tc(0.24)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 2.17%
[DCF Debug] Terminal Value 86.72% ; FCFF base≈746.7m ; Y1≈776.7m ; Y5≈889.8m
Fair Price DCF = 174.1 (EV 26.42b - Net Debt 7.85b = Equity 18.57b / Shares 106.7m; r=5.90% [WACC]; 5y FCF grow 4.24% → 2.90% )
EPS Correlation: -36.59 | EPS CAGR: -46.54% | SUE: -4.0 | # QB: 0
Revenue Correlation: 43.26 | Revenue CAGR: 3.38% | SUE: 0.53 | # QB: 0
EPS current Year (2026-04-30): EPS=8.99 | Chg30d=+0.000 | Revisions Net=+2 | Growth EPS=-11.1% | Growth Revenue=+4.0%
EPS next Year (2027-04-30): EPS=8.04 | Chg30d=+0.033 | Revisions Net=+0 | Growth EPS=+24.3% | Growth Revenue=+2.1%
P/S = 1.2744
P/B = 1.8461
P/EG = 1.6776
Revenue TTM = 8.77b USD
EBIT TTM = -712.5m USD
EBITDA TTM = -188.5m USD
Long Term Debt = 7.04b USD (from longTermDebt, last quarter)
Short Term Debt = 748.2m USD (from shortTermDebt, last quarter)
Debt = 7.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.85b USD (from netDebt column, last quarter)
Enterprise Value = 19.03b USD (11.18b + Debt 7.91b - CCE 62.8m)
Interest Coverage Ratio = -1.86 (Ebit TTM -712.5m / Interest Expense TTM 382.4m)
EV/FCF = 29.95x (Enterprise Value 19.03b / FCF TTM 635.5m)
FCF Yield = 3.34% (FCF TTM 635.5m / Enterprise Value 19.03b)
FCF Margin = 7.24% (FCF TTM 635.5m / Revenue TTM 8.77b)
Net Margin = -13.61% (Net Income TTM -1.19b / Revenue TTM 8.77b)
Gross Margin = 33.72% ((Revenue TTM 8.77b - Cost of Revenue TTM 5.82b) / Revenue TTM)
Gross Margin QoQ = 33.56% (prev 22.46%)
Tobins Q-Ratio = 1.08 (Enterprise Value 19.03b / Total Assets 17.63b)
Interest Expense / Debt = 1.25% (Interest Expense 98.6m / Debt 7.91b)
Taxrate = 24.21% (77.1m / 318.4m)
NOPAT = -540.0m (EBIT -712.5m * (1 - 24.21%)) [loss with tax shield]
Current Ratio = 0.89 (Total Current Assets 2.33b / Total Current Liabilities 2.63b)
Debt / Equity = 1.31 (Debt 7.91b / totalStockholderEquity, last quarter 6.06b)
Debt / EBITDA = -41.65 (negative EBITDA) (Net Debt 7.85b / EBITDA -188.5m)
Debt / FCF = 12.35 (Net Debt 7.85b / FCF TTM 635.5m)
Total Stockholder Equity = 6.24b (last 4 quarters mean from totalStockholderEquity)
RoA = -6.34% (Net Income -1.19b / Total Assets 17.63b)
RoE = -19.12% (Net Income TTM -1.19b / Total Stockholder Equity 6.24b)
RoCE = -5.36% (EBIT -712.5m / Capital Employed (Equity 6.24b + L.T.Debt 7.04b))
RoIC = -3.84% (negative operating profit) (NOPAT -540.0m / Invested Capital 14.07b)
WACC = 4.30% (E(11.18b)/V(19.09b) * Re(6.67%) + D(7.91b)/V(19.09b) * Rd(1.25%) * (1-Tc(0.24)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 2.17%
[DCF Debug] Terminal Value 86.72% ; FCFF base≈746.7m ; Y1≈776.7m ; Y5≈889.8m
Fair Price DCF = 174.1 (EV 26.42b - Net Debt 7.85b = Equity 18.57b / Shares 106.7m; r=5.90% [WACC]; 5y FCF grow 4.24% → 2.90% )
EPS Correlation: -36.59 | EPS CAGR: -46.54% | SUE: -4.0 | # QB: 0
Revenue Correlation: 43.26 | Revenue CAGR: 3.38% | SUE: 0.53 | # QB: 0
EPS current Year (2026-04-30): EPS=8.99 | Chg30d=+0.000 | Revisions Net=+2 | Growth EPS=-11.1% | Growth Revenue=+4.0%
EPS next Year (2027-04-30): EPS=8.04 | Chg30d=+0.033 | Revisions Net=+0 | Growth EPS=+24.3% | Growth Revenue=+2.1%